Qiao Liu

13PUBLICATIONS
9CO-AUTHORS
Gene and molecular therapyCancer therapy (excl. chemotherapy and radiation therapy)Pharmaceutical delivery technologiesPharmacogenomicsTraditional Chinese medicine and treatments
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|May 13, 2026
Cost-effectiveness analysis of mepolizumab among patients with severe asthma from the Chinese societal perspective.

|May 23, 2025
Comparative efficacy and safety of oral hypoglycaemic drugs as adjunctive therapy in the management of type 1 diabetes mellitus: A systematic review and meta-analysis.

Dong Wu, Xiaowu Wang, Qiao Liu

|Oct 18, 2024
Sintilimab plus chemotherapy with or without bevacizumab biosimilar IBI305 in EGFR-mutated non-squamous NSCLC patients who progressed on EGFR TKI therapy: A China-based cost-effectiveness analysis.

Juan Peng, Huiling Xu, Qiao Liu

|Jun 18, 2024
Comparison Between Sotorasib with Docetaxel for the Treatment of Chinese Patients with Previously Treated NSCLC with KRASG12C Mutation: A Cost-Effectiveness Analysis to Inform Drug Pricing.

Lidan Yi, Xiaohui Zeng, Zhen Zhou

|Apr 18, 2024
A China-Based Cost-Effectiveness Analysis of Novel Oral Anticoagulants versus Warfarin in Patients with Left Ventricular Thrombosis.

Shuo Tian, Haitao Zhong, Mengyue Yin

|Apr 17, 2024
Cost-Effectiveness of First-Line Atezolizumab versus Chemotherapy in Non-Small-Cell Lung Cancer Patients Ineligible for Platinum-Containing Regimens.

Lan-Fang Li, Ran Qi, Tian-Tian Wei

Pageof 3

Frequent Collaborators

1 joint publications

Huixian Zhang

1 joint publications

Tongfeng Chen

1 joint publications

Zhen Zhou

1 joint publications

Ran Qi